Buruli Ulcer

Supports further investigation by summarizing state of the art in the field of Buruli ulcer research

Enriches understanding of epidemiology of Buruli ulcer in different geographic regions

Reviews exhaustively the characteristics of Mycobacterium ulcerans disease

Autorentext

Professor Gerd Pluschke, PhD, Head Molecular Immunology, Swiss Tropical and Public Health Institute, Basle, Switzerland.

Katharina Röltgen, PhD, Department of Pathology, Stanford University, Stanford, CA, United States.

Inhalt

Buruli Ulcer: History and Disease Burden.- Buruli Ulcer in Africa.- Buruli Ulcer in Australia.- Mycobacterium Ulcerans Infection in French Guiana; Current State of Knowledge.- Buruli Ulcer in Japan.- Population Genomics and Molecular Epidemiology of Mycobacterium Ulcerans.- Mycolactone: More Than Just a Cytotoxin.- The Immunology of Buruli Ulcer.- Buruli Ulcer in Animals and Experimental Infection Models.- Laboratory Diagnosis of Buruli Ulcer: Challenges and Future Perspectives.- Antimicrobial Treatment of Mycobacterium Ulcerans Infection.- Thermotherapy of Buruli Ulcer.- Secondary Infection of Buruli Ulcer Lesions.- Management of BU-HIV Co-infection.- Social Science Contributions to BU Focused Health Service Research in West-Africa.- Transdisciplinary Research and Action to Stop Buruli Ulcer A Case Study from Philanthropy.

<p